Heparin-induced thrombocytopenia: Difference between revisions
Gerald Chi- (talk | contribs) mNo edit summary |
Gerald Chi- (talk | contribs) mNo edit summary |
||
| Line 31: | Line 31: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Heparin-induced thrombocytopenia history and symptoms|History and Symptoms]] | [[Heparin-induced thrombocytopenia diagnostic criteria|Diagnostic Criteria]] | ||
| [[Heparin-induced thrombocytopenia history and symptoms|History and Symptoms]] | |||
| [[Heparin-induced thrombocytopenia physical examination|Physical Examination]] | | [[Heparin-induced thrombocytopenia physical examination|Physical Examination]] | ||
| [[Heparin-induced thrombocytopenia laboratory findings|Laboratory Findings]] | | [[Heparin-induced thrombocytopenia laboratory findings|Laboratory Findings]] | ||
Revision as of 21:55, 2 June 2016
 |
Resident Survival Guide |
|
Heparin-induced thrombocytopenia |
|
Differentiating Heparin-induced thrombocytopenia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Heparin-induced thrombocytopenia On the Web |
|
American Roentgen Ray Society Images of Heparin-induced thrombocytopenia |
|
Directions to Hospitals Treating Heparin-induced thrombocytopenia |
|
Risk calculators and risk factors for Heparin-induced thrombocytopenia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2], Priyamvada Singh, M.B.B.S. [3], Aric C. Hall, M.D., [4]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Heparin-induced thrombocytopenia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Diagnostic Criteria | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies